Access to Waitlisting and Posttransplant Outcomes in Patients With Failed Kidney Allografts Secondary to Recurrent Glomerulonephritis
Open Access
- 18 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (11) , e1717
Abstract
Background.: Recurrent glomerulonephritis (GN) is an important cause of allograft loss after transplantation when GN is the primary cause of kidney failure. Retransplantation after allograft loss from recurrent disease requires careful consideration. We aimed to determine the probability of relisting and the risk of allograft loss after retransplantation in recipients with prior allograft loss from recurrent GN. Methods.: Using data from the Australia and New Zealand Dialysis and Transplant Registry and multivariable Cox modeling, we compared the probability of waitlisting and allograft loss after second transplantation between those with and without prior allograft loss from recurrent disease. Results.: Of 3276 patients who received a second kidney transplant, 179 (5%) lost their first allograft from recurrent GN. Between 2006 and 2021, 1524 patients with failed first allografts (6% with recurrent GN, 45% with primary GN but no disease recurrence) were relisted for transplantation. Compared with patients without primary GN, the adjusted hazard ratios (95% confidence intervals) for relisting in patients with primary GN, with and without disease recurrence, were 1.09 (0.88-1.34) and 1.16 (1.05-1.29), respectively. The respective adjusted hazard ratios for allograft loss after repeat transplantation were 0.77 (0.59-1) and 1.02 (0.9-1.16). Of the 81 patients who received a second allograft after losing their first allograft to GN recurrence, 18 patients (22%) also lost their second allograft because of recurrent GN. Conclusions.: Patients with prior allograft loss from GN recurrence were not disadvantaged, with comparable waitlist potential and allograft outcome after repeat transplantation. However, >20% of those with prior allograft loss from disease recurrence also lost their second allografts from recurrent disease.Keywords
This publication has 14 references indexed in Scilit:
- Novel Treatment Paradigms: Primary IgA NephropathyKidney International Reports, 2023
- Corrigendum to Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis Kidney International Reports, Volume 8, Issue 1, January 2023, Pages 30–35Kidney International Reports, 2023
- Novel Treatments Paradigms: Membranous NephropathyKidney International Reports, 2023
- The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research ProtocolCanadian Journal of Kidney Health and Disease, 2022
- Recurrent glomerulonephritis after kidney transplantation: a practical approachCurrent Opinion in Organ Transplantation, 2021
- KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney TransplantationTransplantation, 2020
- Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomesKidney International, 2017
- Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantationKidney International, 2017
- The ERA-EDTA database on recurrent glomerulonephritis following renal transplantationNephrology Dialysis Transplantation, 2013
- Risk of Renal Allograft Loss from Recurrent GlomerulonephritisNew England Journal of Medicine, 2002